Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aharon G Freud

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Molecular Diagnostics : JMD|August 14, 2017
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid TumorsJulie W Reeser, Dorrelyn Martin, Jharna Miya, et al.
Blood|August 31, 2018
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and functionSteven D Scoville, Ansel P Nalin, Luxi Chen, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Inhibition of NFAT promotes loss of tissue resident uterine natural killer cells and attendant pregnancy complications in humansRebecca Asiimwe, Brittney Knott, Morgan E Greene, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2017
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κBAaron R Victor, Ansel P Nalin, Wenjuan Dong, et al.
Science Translational Medicine|March 11, 2026
Inhibition of NFAT after human uterus transplant promotes loss of tissue-resident NK cells and attendant pregnancy complicationsRebecca Asiimwe, Brittney Knott, Morgan E Greene, et al.
Oncotarget|November 5, 2017
Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancerMichele R Wing, Julie W Reeser, Amy M Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironmentUriel Y Moreno-Nieves, Joshua K Tay, Saumyaa Saumyaa, et al.
Nature Communications|March 25, 2023
Aiolos represses CD4<sup>+</sup> T cell cytotoxic programming via reciprocal regulation of T<sub>FH</sub> transcription factors and IL-2 sensitivityKaitlin A Read, Devin M Jones, Srijana Pokhrel, et al.
Immunity|September 9, 2018
CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental PathwayLuxi Chen, Youssef Youssef, Cameron Robinson, et al.
Blood Advances|May 30, 2024
Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responsesEdward L Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Molecular Diagnostics : JMD|August 14, 2017
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid TumorsJulie W Reeser, Dorrelyn Martin, Jharna Miya, et al.
Blood|August 31, 2018
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and functionSteven D Scoville, Ansel P Nalin, Luxi Chen, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Inhibition of NFAT promotes loss of tissue resident uterine natural killer cells and attendant pregnancy complications in humansRebecca Asiimwe, Brittney Knott, Morgan E Greene, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2017
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κBAaron R Victor, Ansel P Nalin, Wenjuan Dong, et al.
Science Translational Medicine|March 11, 2026
Inhibition of NFAT after human uterus transplant promotes loss of tissue-resident NK cells and attendant pregnancy complicationsRebecca Asiimwe, Brittney Knott, Morgan E Greene, et al.
Oncotarget|November 5, 2017
Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancerMichele R Wing, Julie W Reeser, Amy M Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironmentUriel Y Moreno-Nieves, Joshua K Tay, Saumyaa Saumyaa, et al.
Nature Communications|March 25, 2023
Aiolos represses CD4<sup>+</sup> T cell cytotoxic programming via reciprocal regulation of T<sub>FH</sub> transcription factors and IL-2 sensitivityKaitlin A Read, Devin M Jones, Srijana Pokhrel, et al.
Immunity|September 9, 2018
CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental PathwayLuxi Chen, Youssef Youssef, Cameron Robinson, et al.
Blood Advances|May 30, 2024
Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responsesEdward L Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed, et al.
Pageof 9